CDISC
P.O. Box 162033
Austin
Texas
78716-2033
United States
Tel: 512-341-9885
Website: http://www.cdisc.org/
Email: swilliams@cdisc.org
32 articles about CDISC
-
Embleema and CDISC Partner to Develop Standards for Cell and Gene Therapy Product Monitoring
5/24/2022
Embleema Inc. and CDISC have announced a collaboration to develop new standards for experimental assays and bioinformatics protocols to facilitate monitoring the activity of Cell and Gene Therapy Products (CGTP).
-
CDISC Welcomes New Members to Board of Directors
1/20/2022
CDISC today announced three new members have joined its Board of Directors: Karen Curran, Brooke Hinkson, and Lisa Lin each began serving a three-year term at the beginning of the year.
-
CDISC and OpenClinica Collaborate to Drive Academic Clinical Research Forward
10/19/2021
CDISC announced that it is collaborating with OpenClinica to improve data collection in clinical studies conducted by academic institutions and researchers with the goal of driving research forward.
-
CDISC and NORD Partner to Develop Data Standards for Rare Diseases
4/22/2021
CDISC and the National Organization for Rare Disorders (NORD ® ) have announced a partnership to develop global data standards for rare diseases. The data standards will be released in a Therapeutic Area User Guide that will be available at no cost on the CDISC website for researchers to leverage in studies to maximize data’s full potential.
-
CDISC Partners with Gevity to Facilitate Use of Electronic Health Record Data in Clinical Research
5/5/2020
CDISC has launched a project that will facilitate the use of electronic health record data in clinical research to achieve efficiencies that expedite global regulatory reviews, contribute to the evaluation of new treatments for patients and drive next generation discovery.
-
CDISC Launches Task Force to Rapidly Develop Standards for COVID-19
3/27/2020
CDISC Standards Supporting the Research Community during an Unprecedented Time
-
CDISC Adds Four New Members and Re-appoints Two to 2020 Board of Directors
1/15/2020
CDISC announced four new members have joined its Board of Directors: Dr. Wenjun Bao, Dr. Mihoko Okada, Dr. Erik Pulkstenis, and Dr. Christina Reith. Each began serving a three-year term at the beginning of the year.
-
Korean CDISC Coordinating Committee Launched at 2019 Korea Summit
12/10/2019
CDISC is pleased to announce the launch of the Korea CDISC Coordinating Committee at the 2019 CDISC Korea Summit held 7 November in Daegu, South Korea.
-
CDISC Publishes First Standard Using Traditional Chinese Medicine
9/18/2019
Released in the form of a User Guide for data managers, statisticians, programmers and study managers, the standard is freely available on the CDISC website.
-
CORRECTING and REPLACING CDISC Publishes First Standard Using Traditional Chinese Medicine
9/18/2019
CDISC is pleased to announce the first release of a global Therapeutic Area Standard using Traditional Chinese Medicine. Specifically, the standard describes how to use CDISC standards to represent data pertaining to coronary artery disease for the treatment of angina.
-
CDISC Founder to Lead ISO/TC 215 Genomics Sub-Committee
8/28/2019
The scope of the Genomics SC is “Standardization of computable data, information, and knowledge, including their representation and metadata, for the application of omics, including but not limited to genomics, transcriptomics and proteomics, to support human health and clinical research.”
-
Pancreatic Cancer Action Network and CDISC Partner to Develop First Therapeutic Area Data Standards for Pancreatic Cancer - Aug. 27, 2019
8/27/2019
Standardization of Medical Research Data Will Lead to Greater Efficiencies, Ease of Sharing, Scientific Collaboration
-
CDISC to Develop Data Standards for Crohn’s Disease With Support from the Helmsley Charitable Trust
4/2/2019
CDISC will develop the first global, non-proprietary clinical data standards for Crohn’s disease with a grant award of $1 million from The Leona M. and Harry B. Helmsley Charitable Trust.
-
New Leaders Join CDISC 2019 Board of Directors
1/17/2019
CDISC today announced three new members have joined its Board of Directors. Dr. Pandu Kulkarni, Dr. Hiroshi Masumoto, and Dr. Zhengqing Li each began serving a three-year term at the beginning of the year.
-
CDISC Names Peter Van Reusel Chief Standards Officer
5/30/2018
CDISC is pleased to announce long-time standards advocate, skilled instructor and current European Liaison, Peter Van Reusel, as the organization’s Chief Standards Officer.
-
CDISC Releases Therapeutic Area User Guide To Accelerate Development Of Safer, More Effective Vaccines
10/5/2017
-
New CDISC Standard Empowers Smarter Research For Diabetic Kidney Disease
7/28/2017
-
CDISC And C-Path Announce Public Review Period For Duchenne Therapeutic Area Standard
6/13/2017
-
CDISC Announces New Standard For Major Depressive Disorder To Foster Development Of New Treatments
4/18/2017
-
CDISC Board Names David R. Bobbitt As New CEO
4/10/2017